Overview

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

Status:
Unknown status
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess which drug is more effective of RamiprinĀ®(ramipril) and TritaceĀ®(ramipril) in the Treatment of Essential Hypertension
Phase:
Phase 4
Details
Lead Sponsor:
Pacific Pharmaceuticals
Treatments:
Ramipril